NEXIEN BIOPHARMA, INC. Quarterly Common Stock, Shares, Issued from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nexien Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2017 to Q3 2024.
  • Nexien Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 70.5M shares, a 8.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 70.5M +5.7M +8.8% Sep 30, 2024 10-Q 2024-11-18
Q2 2024 70.5M +6.45M +10.1% Jun 30, 2024 10-Q 2024-11-18
Q1 2024 67.5M +4.7M +7.49% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 65.3M +3.25M +5.24% Dec 31, 2023 10-Q 2024-02-20
Q3 2023 64.8M +3.5M +5.71% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 64M +3.5M +5.78% Jun 30, 2023 10-K 2024-10-22
Q1 2023 62.8M +2.75M +4.58% Mar 31, 2023 10-Q 2023-05-17
Q4 2022 62M +5.25M +9.25% Dec 31, 2022 10-Q 2023-02-08
Q3 2022 61.3M +5.5M +9.86% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 60.5M +4.75M +8.52% Jun 30, 2022 10-K 2023-09-28
Q1 2022 60M +6.5M +12.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 56.8M +841K +1.5% Dec 31, 2021 10-Q 2022-02-08
Q3 2021 55.8M -9K -0.02% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 55.8M +1.79M +3.31% Jun 30, 2021 10-K 2022-09-28
Q1 2021 53.5M -462K -0.86% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 55.9M +1.95M +3.61% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 55.8M +1.8M +3.33% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 54M +473K +0.88% Jun 30, 2020 10-K 2021-10-12
Q1 2020 54M +268K +0.5% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 54M +268K +0.5% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 54M +9.54M +21.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 53.5M +9.06M +20.4% Jun 30, 2019 10-K 2020-09-28
Q1 2019 53.7M +9.96M +22.8% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 53.7M +9.66M +21.9% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 44.4M +19.3M +77% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 44.4M +11.8M +36.3% Jun 30, 2018 10-K 2019-09-30
Q1 2018 43.8M Mar 31, 2018 10-Q 2018-05-15
Q4 2017 44.1M Dec 31, 2017 10-Q 2018-02-14
Q3 2017 25.1M Sep 30, 2017 10-Q 2017-11-03
Q2 2017 32.6M Jun 30, 2017 10-K 2018-09-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.